B.Riley Financial analyst Mayank Mamtani has maintained their bullish stance on NVAX stock, giving a Buy rating on November 13. Mayank Mamtani’s rating is based on several strategic and financial
B.Riley Financial analyst Mayank Mamtani has maintained their bullish stance on NVAX stock, giving a Buy rating on November 13. Mayank Mamtani’s rating is based on several strategic and financial
Shares of vaccine makers such as Moderna ($MRNA) and Novavax ($NVAX) are down on news that president-elect Donald Trump has nominated Robert F. Kennedy Jr. (RFK Jr.) to lead the
In this recurring series, The Fly recaps where the top analysts on Wall Street say to put your money following the U.S. presidential election. In this edition, President-elect Trump’s team
מניות של חברות כמו Moderna (MRNA), BioNTech (BNTX), Pfizer (PFE), Novavax (NVAX), Vaxcyte (PCVX), ו-GSK (GSK) דעכו עד סוף יום המסחר. זה קרה לאחר דיווחים כי הנשיא הנבחר דונלד טראמפ
Shares of vaccine makers, including Moderna (MRNA), BioNTech (BNTX), Pfizer (PFE), Novavax (NVAX), Vaxcyte (PCVX) and GSK (GSK) moved lower at the end of the trading day following reports that